login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
INTERCEPT PHARMACEUTICALS IN (ICPT) Stock News
USA
- NASDAQ:ICPT -
US45845P1084
-
Common Stock
19
USD
+0.04 (+0.21%)
Last: 11/7/2023, 8:02:20 PM
19
USD
0 (0%)
After Hours:
11/7/2023, 8:02:20 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
ICPT Latest News, Press Relases and Analysis
All
Press Releases
2 years ago - By: Intercept Pharmaceuticals, Inc.
Intercept Announces FDA Acceptance of Supplemental New Drug Application for Ocaliva® (obeticholic acid) for the Treatment of PBC
2 years ago - By: Benzinga
- Mentions:
GILD
CBAY
CymaBay Therapeutics Deal May Not Be Needle Moving For $100B Valued Gilead, But Acquisition Is Reasonably Priced: Analyst
2 years ago - By: Intercept Pharmaceuticals, Inc.
Alfasigma completes acquisition of Intercept Pharmaceuticals, Inc.
2 years ago - By: Benzinga
- Mentions:
HSTM
NXGN
OLK
GPCR
Top 5 Health Care Stocks That Should Keep You Up At Night
2 years ago - By: The Motley Fool
Why Intercept Pharmaceuticals Stock Is Skyrocketing Today
2 years ago - By: InvestorPlace
Why Is Intercept Pharmaceuticals (ICPT) Stock Up 75% Today?
2 years ago - By: InvestorPlace
- Mentions:
NXGN
SPLK
CHS
PKOH
...
Stocks to Sell: 7 Overbought Companies You Ought to Dump Right Now
2 years ago - By: Kahn Swick & Foti, LLC
INTERCEPT PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Intercept Pharmaceuticals, Inc. - ICPT
2 years ago - By: Seeking Alpha
Intercept stock drops amid report from European Medicines Agency on Ocaliva (NASDAQ:ICPT)
2 years ago - By: The Motley Fool
- Mentions:
CBAY
Why CymaBay Therapeutics Stock Is Jumping Today
2 years ago - By: Brodsky & Smith LLC
- Mentions:
SPLK
AMTI
NXGN
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Intercept Pharmaceuticals, Inc. (Nasdaq – ICPT), Splunk, Inc. (Nasdaq – SPLK), Applied Molecular Transport Inc. (Nasdaq - AMTI), NextGen Healthcare, Inc. (Nasdaq –
2 years ago - By: Seeking Alpha
Intercept failed NASH candidate precipitated Alfasigma acquisition
2 years ago - By: Kahn Swick & Foti, LLC
INTERCEPT PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Intercept Pharmaceuticals, Inc. - ICPT
2 years ago - By: Seeking Alpha
Canaccord cuts Intercept to hold, calls Alfasigma deal
2 years ago - By: Seeking Alpha
Intercept Pharma unlikely to see rival offers, other roadblocks, analysts say
2 years ago - By: Ademi LLP
Shareholder Alert: Ademi LLP investigates whether Intercept Pharmaceuticals, Inc. has obtained a Fair Price in its transaction with Alfasigma
2 years ago - By: Brodsky & Smith LLC
- Mentions:
SPLK
AMTI
NXGN
CSCO
...
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Intercept Pharmaceuticals, Inc. (Nasdaq – ICPT), Splunk, Inc. (Nasdaq – SPLK), Applied Molecular Transport Inc. (Nasdaq - AMTI), NextGen Healthcare, Inc. (Nasdaq –
2 years ago - By: Halper Sadeh LLC
ICPT Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Intercept Pharmaceuticals, Inc. Is Fair to Shareholders
2 years ago - By: Intercept Pharmaceuticals, Inc.
Alfasigma to Acquire Intercept Pharmaceuticals for $19.00 per Share in Cash, Expanding the Global Footprint of Alfasigma Via a Leader in Rare and Serious Liver Diseases
Please enable JavaScript to continue using this application.